Skip to content

Cold as a therapeutic strategy to improve cardiovascular risk factors

Cold as a therapeutic strategy to improve cardiovascular risk factors - Cold exposure and cardiovascular risk factors

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON56482
Enrollment
170
Registered
2023-05-29
Start date
2023-12-13
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiovascular diseases cardiovascular diseases

Interventions

Cold exposure using either a cooling vest or cold showers&nbsp

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Part 1 - Pilot study  For the pilot study, a subject must meet the following criteria:  - Males or females with Europid ethnicity OR with South Asian ethnicity (South  Asian ethnicity is defined as having 4 grandparents that originally descended  from either Bangladesh, India, Nepal, Pakistan, Afghanistan, Bhudan or Sri  Lanka or are from Hindu-Surinamese descent) - Age between 20 and 50 years  - Living with overweight or obesity (Europids: BMI 25 - 35 kg/m2; South Asians:  BMI 23 - 35 kg/m2, since a BMI of 23 is already regarded as *overweight* in  South Asians; or a BMI < 35 kg/m² and a waist circumference of >=80 cm for  females; or a BMI < 35 kg/m² and a waist circumference of >=94 cm for male  Europids; or a BMI < 35 kg/m² and a waist circumference of >=90 cm for male  South Asians) (BMI 25 - 35 kg/m2) - Capable of giving written informed consent Part 2 - Cooling vest study  In order to be eligible to participate in this study, a subject must meet all  of the following criteria:  - Males or females with Europid ethnicity OR with South Asian ethnicity (South  Asian ethnicity is defined as having 4 grandparents that originally descended  from either Bangladesh, India, Nepal, Pakistan, Afghanistan, Bhudan or Sri  Lanka or are from Hindu-Surinamese descent) - Age between 20 and 50 years (South Asians: 20 to 55 years) - Living with overweight or obesity (Europids: BMI 25 - 35 kg/m2; South Asians:  BMI 23 - 35 kg/m2, since a BMI of 23 is already regarded as *overweight* in  South Asians; or a BMI < 35 kg/m² and a waist circumference of >=80 cm for  females; or a BMI < 35 kg/m² and a waist circumference of >=94 cm for male  Europids; or a BMI < 35 kg/m² and a waist circumference of >=90 cm for male  South Asians) - Capable of giving written informed consent - Able to comply with the requirements and restrictions listed in the informed  consent form Part 3 - Cold shower study  Inclusion criteria are largely similar compared with part 2, but here only  females with Europid ethnicity will be included.Part 4 - Implementation studyInclusion criteria are largely similar compared with part 2, but here only females with Europid ethnicity will be included. 

Exclusion criteria

Exclusion criteria: Part 1 - Pilot study A potential subject who meets any of the following criteria will be excluded  from participation in the pilot study:  - Any cardiovascular disease (i.e. ischemic heart disease, arrythmias, severe  heart failure, untreated hypertension)  - A first-degree family member with sudden cardiac death  - Abuse of alcohol (regularly more than 2 glasses per day) or use of any drugs  of abuse - Smoking  - Pregnancy  - Active cold water swimmers (at least once weekly during winter) - Taking cold showers (in the past 6 weeks at least once weekly) In case potential participants are active cold water swimmers or take cold  showers, after a wash-out period of at least 6 weeks, they can participate in  Part 1.  Part 2 - Cooling vest study  A potential subject who meets any of the following criteria will be excluded  from participation in this study:  - Diabetes mellitus (determined on basis of fasting glucose levels defined by  ADA criteria)  - Any other active endocrine disease (thyroid disease, any signs of Cushing*s  syndrome, adrenal disease and lipid-associated disorders such as familial  hypercholesterolemia)  - Any cardiovascular disease (i.e. ischemic heart disease, arrythmias, severe  heart failure, untreated hypertension)  - A first-degree family member with sudden cardiac death  - Any chronic renal or hepatic disease  - Abnormal laboratory values that could point towards underlying (metabolic,  (auto)immune) disease and/or that could influence primary and secondary  outcomes (e.g. dyslipidemia, leukopenia, abnormal liver function)  - Abuse of alcohol (regularly more than 2 glasses per day) or use of any drugs  - Smoking  - Pregnancy  - Participation in an intensive weight-loss program or vigorous exercise  program during the last year before the start of the study  - Use of any medication that may influence energy metabolism (e.g. ß-blockers,  statins, antidepressants, antipsychotics), or may affect blood clotting (e.g.  blood thinners).  - Active cold water swimmers (at least once weekly during winter in the past 3  months) - Taking cold showers (in the past 3 months at least once weekly) - Participation in another research project  Part 3 - Cold shower study Equal to part 2, but exclusion criterium is also male gender Part 4 - Implementation study  Equal to part 2, but exclusion criterium is also male gender 

Design outcomes

Primary

MeasureTime frame
Part 1: Thermal comfort and practicalities upon wearing either cooling vest for 5 days Part 2 and 3: Effects of cold exposure through wearing a cooling vest (part 1) or daily cold showers (part 2) on fat mass Part 4: Effects of cold exposure through wearing a cooling vest at fixed or flexible times on fat mass.

Secondary

MeasureTime frame
Part 1: Resting energy expenditure upon wearing either cooling vest for 5 days Part 2 and 3: Cold-induced resting energy expenditure, lipid metabolism, hepatic steatosis, skin temperature, serum markers for glucose metabolism, immune cell phenotype and response of these cells to inflammatory stimuli, markers of biological stress, experienced stress and quality of life upon wearing a cooling vest for 2 h/day for 6 weeks or after daily cold showers Part 4: plasma lipid levels, serum markers for inflammation, glucose metabolism and experienced stress and quality of life 

Countries

Netherlands

Contacts

Public ContactMR Boon

Leids Universitair Medisch Centrum

m.r.boon@lumc.nl0648126425

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 22, 2026